Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...